K. Noordam

发表

Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births

B. Shields, S. Ellard, M. Małecki, 2009, Diabetologia.

Genotypic and phenotypic characterization of Noonan syndrome: New data and review of the literature

M. Patton, M. Tartaglia, R. Tamminga, 2005, American journal of medical genetics. Part A.

High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia.

C. Sweep, G. Jager, B. Otten, 2001, The Journal of clinical endocrinology and metabolism.

Spinal Stenosis with Paraparesis in Albright Hereditary Osteodystrophy

R. Bartels, E. V. van Lindert, K. Noordam, 2008, Pediatric Neurosurgery.

Expanding the Genetic Spectrum of Noonan Syndrome

K. Noordam, 2007, Hormone Research in Paediatrics.

Perceived motor problems in daily life: Focus group interviews with people with Noonan syndrome and their relatives

M. N. D. Nijhuis-van der Sanden, J. Draaisma, I. van der Burgt, 2016, American journal of medical genetics. Part A.

Exercise training improves physical fitness and vascular function in children with type 1 diabetes

M. Hopman, M. N. D. Nijhuis-van der Sanden, D. Thijssen, 2011, Diabetes, obesity & metabolism.

Quantitative calcaneal ultrasound parameters and bone mineral density at final height in girls treated with depot gonadotrophin-releasing hormone agonist for central precocious puberty or idiopathic short stature

J. V. D. van den Bergh, B. Otten, K. Noordam, 2003, European Journal of Pediatrics.

High serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) during high-dose GH treatment in short children born small for gestational age.

A. Hokken-Koelega, R. Odink, K. Noordam, 2006, The Journal of clinical endocrinology and metabolism.

Absence of increased height velocity in the first year of life in untreated children with simple virilizing congenital adrenal hyperplasia.

G. Borm, B. Otten, K. Noordam, 2006, The Journal of clinical endocrinology and metabolism.

EXTENSIVE CLINICAL EXPERIENCE Absence of Increased Height Velocity in the First Year of Life in Untreated Children with Simple Virilizing Congenital Adrenal Hyperplasia

G. Borm, B. Otten, K. Noordam, 2006 .

The Relationship between Clinical Severity of Noonan's Syndrome and Growth, Growth Hormone (GH) Secretion and Response to GH Treatment

B. Otten, I. van der Burgt, K. Noordam, 2002, Journal of pediatric endocrinology & metabolism : JPEM.

Glucokinase-Linked Hypoglycemia

H. Christesen, K. Noordam, K. Herold, 2004 .

Genetics and Variation in Phenotype in Noonan Syndrome

B. Otten, I. van der Burgt, K. Noordam, 2004, Hormone Research in Paediatrics.

Benign course after acute high dose levothyroxine intoxication in a 3-year-old boy

P. V. van Setten, K. Noordam, S. Hartman, 2017, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

Growth hormone producing prolactinoma in juvenile cystinosis: a simple coincidence?

E. Levtchenko, K. Noordam, M. Willemsen, 2007, Pediatric Nephrology.

Variable phenotypic expression in a large Noonan syndrome family segregating a novel SOS1 mutation

T. Rinne, J. Draaisma, I. van der Burgt, 2017, American journal of medical genetics. Part A.

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation

L. Kiemeney, A. V. van Kessel, R. Kuiper, 2011, European Journal of Human Genetics.

Noonan syndrome, the SOS1 gene and embryonal rhabdomyosarcoma

A. V. van Kessel, R. Kuiper, M. Ligtenberg, 2010, Genes, chromosomes & cancer.

Denys–Drash syndrome and congenital diaphragmatic hernia: Another case with the 1097G > A(Arg366His) mutation

B. V. van Bon, I. van der Burgt, K. Noordam, 2008, American journal of medical genetics. Part A.

Newborn screening for congenital adrenal hyperplasia in the Netherlands.

C. Noordam, B. Otten, K. Noordam, 2001, Pediatrics.

Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations.

A. Hattersley, S. Ellard, A. Gloyn, 2003, Diabetes.

Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation

A. Hattersley, M. Hadders‐Algra, J. Jukema, 2008, Diabetic medicine : a journal of the British Diabetic Association.

Short Stature in Noonan Syndrome: Results of Growth Hormone Treatment in KIGS

B. Otten, K. Noordam, 2007 .

Denys–Drash syndrome and congenital diaphragmatic hernia: Another case with the 1097G > A(Arg366His) mutation

B. V. van Bon, I. van der Burgt, K. Noordam, 2008, American journal of medical genetics. Part A.